New Filings At The EMA
Executive SummaryNew medicines under evaluation at the European Medicines Agency.
You may also be interested in...
The EU product information for Ibrance, Verzenios and Kisqali is being updated to include interstitial lung disease and pneumonitis. The change has already been implemented in the US.